Hemosphere
Kennesaw
About Hemosphere
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Total funding: $9.3M
- Funding stage: M&A
- Last round: Series A (Apr 2010)
- Website: herograft.com
- Phone: +1 770-590-3753
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/hemosphere-2418395 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.